Ilse M. J. Kant
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ilse M. J. Kant has a total of 114 co-authors. Here are the top co-authors by number of shared publications:
- Jeroen de Bresser
Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands
8 shared publications - Claudia Spies
Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Anesthesiology and Intensive Care Medicine (CCM | CVK), Augustenburger Platz 1, 13353 Berlin, Germany
6 shared publications - Jeroen Hendrikse
Department of Radiology, University Medical Centre Utrecht, Utrecht University, the Netherlands
5 shared publications - Anne A. H. de Hond
Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands
4 shared publications - Ewout Willem Steyerberg
University Medical Center Utrecht
4 shared publications Simone J.T. van Montfort
4 shared publications
Latest Publications
- Open Access
- 21 November 2026
- Published by Elsevier in British Journal of Anaesthesia
Postoperative delirium is associated with accelerated brain ageing: an exploratory cohort study
- 21 November 2026
- Published by Elsevier in British Journal of Anaesthesia
Open AccessPostoperative delirium is associated with accelerated brain ageing: an exploratory cohort study
- Top Cited PapersOpen Access
- 23 September 2024
- Published by JMIR Publications Inc. in JMIR AI
- Vol. 3 (1) , e60020
Impact of a Digital Scribe System on Clinical Documentation Time and Quality: Usability Study
Background: Physicians spend approximately half of their time on administrative tasks, which is one of the leading causes of physician burnout and decreased work satisfaction. The implementation of natural language processing–assisted clinical documentation tools may provide a solution. Objective: This study investigates the impact of a commercially available Dutch digital scribe system on clinical documentation efficiency and quality. Methods: Medical students with experience in clinical practice and documentation (n=22) created a total of 430 summaries of mock consultations and recorded the time they spent on this task. The consultations were summarized using 3 methods: manual summaries, fully automated summaries, and automated summaries with manual editing. We then randomly reassigned the summaries and evaluated their quality using a modified version of the Physician Documentation Quality Instrument (PDQI-9). We compared the differences between the 3 methods in descriptive statistics, quantitative text metrics (word count and lexical diversity), the PDQI-9, Recall-Oriented Understudy for Gisting Evaluation scores, and BERTScore. Results: The median time for manual summarization was 202 seconds against 186 seconds for editing an automatic summary. Without editing, the automatic summaries attained a poorer PDQI-9 score than manual summaries (median PDQI-9 score 25 vs 31, P<.001, ANOVA test). Automatic summaries were found to have higher word counts but lower lexical diversity than manual summaries (P<.001, independent t test). The study revealed variable impacts on PDQI-9 scores and summarization time across individuals. Generally, students viewed the digital scribe system as a potentially useful tool, noting its ease of use and time-saving potential, though some criticized the summaries for their greater length and rigid structure. Conclusions: This study highlights the potential of digital scribes in improving clinical documentation processes by offering a first summary draft for physicians to edit, thereby reducing documentation time without compromising the quality of patient records. Furthermore, digital scribes may be more beneficial to some physicians than to others and could play a role in improving the reusability of clinical documentation. Future studies should focus on the impact and quality of such a system when used by physicians in clinical practice.
- 23 September 2024
- Published by JMIR Publications Inc. in JMIR AI
- Vol. 3 (1) , e60020
Top Cited PapersOpen AccessImpact of a Digital Scribe System on Clinical Documentation Time and Quality: Usability Study
Background: Physicians spend approximately half of their time on administrative tasks, which is one of the leading causes of physician burnout and decreased work satisfaction. The implementation of natural language processing–assisted clinical documentation tools may provide a solution. Objective: This study investigates the impact of a commercially available Dutch digital scribe system on clinical documentation efficiency and quality. Methods: Medical students with experience in clinical practice and documentation (n=22) created a total of 430 summaries of mock consultations and recorded the time they spent on this task. The consultations were summarized using 3 methods: manual summaries, fully automated summaries, and automated summaries with manual editing. We then randomly reassigned the summaries and evaluated their quality using a modified version of the Physician Documentation Quality Instrument (PDQI-9). We compared the differences between the 3 methods in descriptive statistics, quantitative text metrics (word count and lexical diversity), the PDQI-9, Recall-Oriented Understudy for Gisting Evaluation scores, and BERTScore. Results: The median time for manual summarization was 202 seconds against 186 seconds for editing an automatic summary. Without editing, the automatic summaries attained a poorer PDQI-9 score than manual summaries (median PDQI-9 score 25 vs 31, P<.001, ANOVA test). Automatic summaries were found to have higher word counts but lower lexical diversity than manual summaries (P<.001, independent t test). The study revealed variable impacts on PDQI-9 scores and summarization time across individuals. Generally, students viewed the digital scribe system as a potentially useful tool, noting its ease of use and time-saving potential, though some criticized the summaries for their greater length and rigid structure. Conclusions: This study highlights the potential of digital scribes in improving clinical documentation processes by offering a first summary draft for physicians to edit, thereby reducing documentation time without compromising the quality of patient records. Furthermore, digital scribes may be more beneficial to some physicians than to others and could play a role in improving the reusability of clinical documentation. Future studies should focus on the impact and quality of such a system when used by physicians in clinical practice.
- Top Cited PapersOpen Access
- 8 May 2024
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 172, 111387
Don't be misled: 3 misconceptions about external validation of clinical prediction models
- 8 May 2024
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 172, 111387
Top Cited PapersOpen AccessDon't be misled: 3 misconceptions about external validation of clinical prediction models
- Open Access
- 18 January 2024
- Published by JMIR Publications Inc. in JMIR Medical Informatics
- Vol. 12 (1) , e51925
Predicting Depression Risk in Patients With Cancer Using Multimodal Data: Algorithm Development Study
Background: Patients with cancer starting systemic treatment programs, such as chemotherapy, often develop depression. A prediction model may assist physicians and health care workers in the early identification of these vulnerable patients. Objective: This study aimed to develop a prediction model for depression risk within the first month of cancer treatment. Methods: We included 16,159 patients diagnosed with cancer starting chemo- or radiotherapy treatment between 2008 and 2021. Machine learning models (eg, least absolute shrinkage and selection operator [LASSO] logistic regression) and natural language processing models (Bidirectional Encoder Representations from Transformers [BERT]) were used to develop multimodal prediction models using both electronic health record data and unstructured text (patient emails and clinician notes). Model performance was assessed in an independent test set (n=5387, 33%) using area under the receiver operating characteristic curve (AUROC), calibration curves, and decision curve analysis to assess initial clinical impact use. Results: Among 16,159 patients, 437 (2.7%) received a depression diagnosis within the first month of treatment. The LASSO logistic regression models based on the structured data (AUROC 0.74, 95% CI 0.71-0.78) and structured data with email classification scores (AUROC 0.74, 95% CI 0.71-0.78) had the best discriminative performance. The BERT models based on clinician notes and structured data with email classification scores had AUROCs around 0.71. The logistic regression model based on email classification scores alone performed poorly (AUROC 0.54, 95% CI 0.52-0.56), and the model based solely on clinician notes had the worst performance (AUROC 0.50, 95% CI 0.49-0.52). Calibration was good for the logistic regression models, whereas the BERT models produced overly extreme risk estimates even after recalibration. There was a small range of decision thresholds for which the best-performing model showed promising clinical effectiveness use. The risks were underestimated for female and Black patients. Conclusions: The results demonstrated the potential and limitations of machine learning and multimodal models for predicting depression risk in patients with cancer. Future research is needed to further validate these models, refine the outcome label and predictors related to mental health, and address biases across subgroups.
- 18 January 2024
- Published by JMIR Publications Inc. in JMIR Medical Informatics
- Vol. 12 (1) , e51925
Open AccessPredicting Depression Risk in Patients With Cancer Using Multimodal Data: Algorithm Development Study
Background: Patients with cancer starting systemic treatment programs, such as chemotherapy, often develop depression. A prediction model may assist physicians and health care workers in the early identification of these vulnerable patients. Objective: This study aimed to develop a prediction model for depression risk within the first month of cancer treatment. Methods: We included 16,159 patients diagnosed with cancer starting chemo- or radiotherapy treatment between 2008 and 2021. Machine learning models (eg, least absolute shrinkage and selection operator [LASSO] logistic regression) and natural language processing models (Bidirectional Encoder Representations from Transformers [BERT]) were used to develop multimodal prediction models using both electronic health record data and unstructured text (patient emails and clinician notes). Model performance was assessed in an independent test set (n=5387, 33%) using area under the receiver operating characteristic curve (AUROC), calibration curves, and decision curve analysis to assess initial clinical impact use. Results: Among 16,159 patients, 437 (2.7%) received a depression diagnosis within the first month of treatment. The LASSO logistic regression models based on the structured data (AUROC 0.74, 95% CI 0.71-0.78) and structured data with email classification scores (AUROC 0.74, 95% CI 0.71-0.78) had the best discriminative performance. The BERT models based on clinician notes and structured data with email classification scores had AUROCs around 0.71. The logistic regression model based on email classification scores alone performed poorly (AUROC 0.54, 95% CI 0.52-0.56), and the model based solely on clinician notes had the worst performance (AUROC 0.50, 95% CI 0.49-0.52). Calibration was good for the logistic regression models, whereas the BERT models produced overly extreme risk estimates even after recalibration. There was a small range of decision thresholds for which the best-performing model showed promising clinical effectiveness use. The risks were underestimated for female and Black patients. Conclusions: The results demonstrated the potential and limitations of machine learning and multimodal models for predicting depression risk in patients with cancer. Future research is needed to further validate these models, refine the outcome label and predictors related to mental health, and address biases across subgroups.
- Open Access
- 24 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S10)
MRI phenotypes of the brain are related to long‐term dementia outcome in community‐dwelling older adults
Background: Individual brain MRI markers only show at best a modest association with long‐term occurrence of dementia. Therefore, it is challenging to accurately identify individuals at increased risk for dementia. We aimed to identify different brain MRI phenotypes by combined hierarchical clustering analysis based on neurodegenerative and neurovascular brain MRI markers in community‐dwelling individuals. Within each of these brain MRI phenotype subgroups, we determined the long‐term dementia risk.Method: A hierarchical clustering analysis based on combined brain MRI markers in community‐dwelling individuals of the Age‐Gene/Environment Susceptibility (AGES) Reykjavik Study (n = 3056) was applied to identify different brain MRI phenotypes. Brain MRI markers used in the hierarchical clustering analysis were brain volumes for the estimation of brain atrophy, WMH markers (volume and shape), brain infarcts, microbleeds, and enlarged perivascular spaces.Result: We identified 14 distinct subgroups of individuals with different brain MRI phenotypes (figure 1 and figure 2). The brain MRI phenotypes of the subgroups ranged from limited burden (subgroup (S) 12), mostly atrophy and infarcts (S14), mostly irregularly shaped WMH and atrophy (S3) to a multi‐burden subgroup (S2). These subgroups had a different long‐term risk for dementia (mean time to follow‐up: 9.9 ± 2.6 years; hazard ratio ranging from 4.1 (95%‐CI: 3.19‐13.40) to 13.8 (95%‐CI: 4.28‐44.37); see figure 3); especially the multi‐burden brain MRI phenotype showed an increased risk compared to the reference group (HR: 13.8 (95%‐CI: 4.28‐44.37)).Conclusion: Our results indicate that distinct brain MRI phenotypes are related to different long‐term risks of developing dementia. Brain MRI phenotypes may assist in an improved understanding of the structural correlates of dementia predisposition. These findings may in the future be useful to determine patient prognosis and may aid in patient selection for future treatment studies.
- 24 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S10)
Open AccessMRI phenotypes of the brain are related to long‐term dementia outcome in community‐dwelling older adults
Background: Individual brain MRI markers only show at best a modest association with long‐term occurrence of dementia. Therefore, it is challenging to accurately identify individuals at increased risk for dementia. We aimed to identify different brain MRI phenotypes by combined hierarchical clustering analysis based on neurodegenerative and neurovascular brain MRI markers in community‐dwelling individuals. Within each of these brain MRI phenotype subgroups, we determined the long‐term dementia risk.Method: A hierarchical clustering analysis based on combined brain MRI markers in community‐dwelling individuals of the Age‐Gene/Environment Susceptibility (AGES) Reykjavik Study (n = 3056) was applied to identify different brain MRI phenotypes. Brain MRI markers used in the hierarchical clustering analysis were brain volumes for the estimation of brain atrophy, WMH markers (volume and shape), brain infarcts, microbleeds, and enlarged perivascular spaces.Result: We identified 14 distinct subgroups of individuals with different brain MRI phenotypes (figure 1 and figure 2). The brain MRI phenotypes of the subgroups ranged from limited burden (subgroup (S) 12), mostly atrophy and infarcts (S14), mostly irregularly shaped WMH and atrophy (S3) to a multi‐burden subgroup (S2). These subgroups had a different long‐term risk for dementia (mean time to follow‐up: 9.9 ± 2.6 years; hazard ratio ranging from 4.1 (95%‐CI: 3.19‐13.40) to 13.8 (95%‐CI: 4.28‐44.37); see figure 3); especially the multi‐burden brain MRI phenotype showed an increased risk compared to the reference group (HR: 13.8 (95%‐CI: 4.28‐44.37)).Conclusion: Our results indicate that distinct brain MRI phenotypes are related to different long‐term risks of developing dementia. Brain MRI phenotypes may assist in an improved understanding of the structural correlates of dementia predisposition. These findings may in the future be useful to determine patient prognosis and may aid in patient selection for future treatment studies.
- Open Access
- 17 August 2023
- Published by JMIR Publications Inc. in JMIR Preprints
Predicting Depression Risk in Patients With Cancer Using Multimodal Data: Algorithm Development Study (Preprint)
BACKGROUND Patients with cancer starting systemic treatment programs, such as chemotherapy, often develop depression. A prediction model may assist physicians and health care workers in the early identification of these vulnerable patients. OBJECTIVE This study aimed to develop a prediction model for depression risk within the first month of cancer treatment. METHODS We included 16,159 patients diagnosed with cancer starting chemo- or radiotherapy treatment between 2008 and 2021. Machine learning models (eg, least absolute shrinkage and selection operator [LASSO] logistic regression) and natural language processing models (Bidirectional Encoder Representations from Transformers [BERT]) were used to develop multimodal prediction models using both electronic health record data and unstructured text (patient emails and clinician notes). Model performance was assessed in an independent test set (n=5387, 33%) using area under the receiver operating characteristic curve (AUROC), calibration curves, and decision curve analysis to assess initial clinical impact use. RESULTS Among 16,159 patients, 437 (2.7%) received a depression diagnosis within the first month of treatment. The LASSO logistic regression models based on the structured data (AUROC 0.74, 95% CI 0.71-0.78) and structured data with email classification scores (AUROC 0.74, 95% CI 0.71-0.78) had the best discriminative performance. The BERT models based on clinician notes and structured data with email classification scores had AUROCs around 0.71. The logistic regression model based on email classification scores alone performed poorly (AUROC 0.54, 95% CI 0.52-0.56), and the model based solely on clinician notes had the worst performance (AUROC 0.50, 95% CI 0.49-0.52). Calibration was good for the logistic regression models, whereas the BERT models produced overly extreme risk estimates even after recalibration. There was a small range of decision thresholds for which the best-performing model showed promising clinical effectiveness use. The risks were underestimated for female and Black patients. CONCLUSIONS The results demonstrated the potential and limitations of machine learning and multimodal models for predicting depression risk in patients with cancer. Future research is needed to further validate these models, refine the outcome label and predictors related to mental health, and address biases across subgroups.
- 17 August 2023
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessPredicting Depression Risk in Patients With Cancer Using Multimodal Data: Algorithm Development Study (Preprint)
BACKGROUND Patients with cancer starting systemic treatment programs, such as chemotherapy, often develop depression. A prediction model may assist physicians and health care workers in the early identification of these vulnerable patients. OBJECTIVE This study aimed to develop a prediction model for depression risk within the first month of cancer treatment. METHODS We included 16,159 patients diagnosed with cancer starting chemo- or radiotherapy treatment between 2008 and 2021. Machine learning models (eg, least absolute shrinkage and selection operator [LASSO] logistic regression) and natural language processing models (Bidirectional Encoder Representations from Transformers [BERT]) were used to develop multimodal prediction models using both electronic health record data and unstructured text (patient emails and clinician notes). Model performance was assessed in an independent test set (n=5387, 33%) using area under the receiver operating characteristic curve (AUROC), calibration curves, and decision curve analysis to assess initial clinical impact use. RESULTS Among 16,159 patients, 437 (2.7%) received a depression diagnosis within the first month of treatment. The LASSO logistic regression models based on the structured data (AUROC 0.74, 95% CI 0.71-0.78) and structured data with email classification scores (AUROC 0.74, 95% CI 0.71-0.78) had the best discriminative performance. The BERT models based on clinician notes and structured data with email classification scores had AUROCs around 0.71. The logistic regression model based on email classification scores alone performed poorly (AUROC 0.54, 95% CI 0.52-0.56), and the model based solely on clinician notes had the worst performance (AUROC 0.50, 95% CI 0.49-0.52). Calibration was good for the logistic regression models, whereas the BERT models produced overly extreme risk estimates even after recalibration. There was a small range of decision thresholds for which the best-performing model showed promising clinical effectiveness use. The risks were underestimated for female and Black patients. CONCLUSIONS The results demonstrated the potential and limitations of machine learning and multimodal models for predicting depression risk in patients with cancer. Future research is needed to further validate these models, refine the outcome label and predictors related to mental health, and address biases across subgroups.
- Open Access
- 5 January 2023
- Published by JMIR Publications Inc. in JMIR Human Factors
- Vol. 10, e39114
Intensive Care Unit Physicians’ Perspectives on Artificial Intelligence–Based Clinical Decision Support Tools: Preimplementation Survey Study
Background: Artificial intelligence–based clinical decision support (AI-CDS) tools have great potential to benefit intensive care unit (ICU) patients and physicians. There is a gap between the development and implementation of these tools. Objective: We aimed to investigate physicians’ perspectives and their current decision-making behavior before implementing a discharge AI-CDS tool for predicting readmission and mortality risk after ICU discharge. Methods: We conducted a survey of physicians involved in decision-making on discharge of patients at two Dutch academic ICUs between July and November 2021. Questions were divided into four domains: (1) physicians’ current decision-making behavior with respect to discharging ICU patients, (2) perspectives on the use of AI-CDS tools in general, (3) willingness to incorporate a discharge AI-CDS tool into daily clinical practice, and (4) preferences for using a discharge AI-CDS tool in daily workflows. Results: Most of the 64 respondents (of 93 contacted, 69%) were familiar with AI (62/64, 97%) and had positive expectations of AI, with 55 of 64 (86%) believing that AI could support them in their work as a physician. The respondents disagreed on whether the decision to discharge a patient was complex (23/64, 36% agreed and 22/64, 34% disagreed); nonetheless, most (59/64, 92%) agreed that a discharge AI-CDS tool could be of value. Significant differences were observed between physicians from the 2 academic sites, which may be related to different levels of involvement in the development of the discharge AI-CDS tool. Conclusions: ICU physicians showed a favorable attitude toward the integration of AI-CDS tools into the ICU setting in general, and in particular toward a tool to predict a patient’s risk of readmission and mortality within 7 days after discharge. The findings of this questionnaire will be used to improve the implementation process and training of end users.
- 5 January 2023
- Published by JMIR Publications Inc. in JMIR Human Factors
- Vol. 10, e39114
Open AccessIntensive Care Unit Physicians’ Perspectives on Artificial Intelligence–Based Clinical Decision Support Tools: Preimplementation Survey Study
Background: Artificial intelligence–based clinical decision support (AI-CDS) tools have great potential to benefit intensive care unit (ICU) patients and physicians. There is a gap between the development and implementation of these tools. Objective: We aimed to investigate physicians’ perspectives and their current decision-making behavior before implementing a discharge AI-CDS tool for predicting readmission and mortality risk after ICU discharge. Methods: We conducted a survey of physicians involved in decision-making on discharge of patients at two Dutch academic ICUs between July and November 2021. Questions were divided into four domains: (1) physicians’ current decision-making behavior with respect to discharging ICU patients, (2) perspectives on the use of AI-CDS tools in general, (3) willingness to incorporate a discharge AI-CDS tool into daily clinical practice, and (4) preferences for using a discharge AI-CDS tool in daily workflows. Results: Most of the 64 respondents (of 93 contacted, 69%) were familiar with AI (62/64, 97%) and had positive expectations of AI, with 55 of 64 (86%) believing that AI could support them in their work as a physician. The respondents disagreed on whether the decision to discharge a patient was complex (23/64, 36% agreed and 22/64, 34% disagreed); nonetheless, most (59/64, 92%) agreed that a discharge AI-CDS tool could be of value. Significant differences were observed between physicians from the 2 academic sites, which may be related to different levels of involvement in the development of the discharge AI-CDS tool. Conclusions: ICU physicians showed a favorable attitude toward the integration of AI-CDS tools into the ICU setting in general, and in particular toward a tool to predict a patient’s risk of readmission and mortality within 7 days after discharge. The findings of this questionnaire will be used to improve the implementation process and training of end users.
- Open Access
- 1 January 2023
- Published by Oxford University Press (OUP) in Neuro-Oncology Advances
- Vol. 5 (1) , vdad133
MRI phenotypes of glioblastomas early after treatment are suggestive of overall patient survival
Distinguishing true tumor progression (TP) from treatment-induced abnormalities (eg, pseudo-progression (PP) after radiotherapy) on conventional MRI scans remains challenging in patients with a glioblastoma. We aimed to establish brain MRI phenotypes of glioblastomas early after treatment by combined analysis of structural and perfusion tumor characteristics and assessed the relation with recurrence rate and overall survival time. Structural and perfusion MR images of 67 patients at 3 months post-radiotherapy were visually scored by a neuroradiologist. In total 23 parameters were predefined and used for hierarchical clustering analysis. Progression status was assessed based on the clinical course of each patient 9 months after radiotherapy (or latest available). Multivariable Cox regression models were used to determine the association between the phenotypes, recurrence rate, and overall survival. We established 4 subgroups with significantly different tumor MRI characteristics, representing distinct MRI phenotypes of glioblastomas: TP and PP rates did not differ significantly between subgroups. Regression analysis showed that patients in subgroup 1 (characterized by having mostly small and ellipsoid nodular enhancing lesions with some hyper-perfusion) had a significant association with increased mortality at 9 months (HR: 2.6 (CI: 1.1–6.3); P = .03) with a median survival time of 13 months (compared to 22 months of subgroup 2). Our study suggests that distinct MRI phenotypes of glioblastomas at 3 months post-radiotherapy can be indicative of overall survival, but does not aid in differentiating TP from PP. The early prognostic information our method provides might in the future be informative for prognostication of glioblastoma patients.
- 1 January 2023
- Published by Oxford University Press (OUP) in Neuro-Oncology Advances
- Vol. 5 (1) , vdad133
Open AccessMRI phenotypes of glioblastomas early after treatment are suggestive of overall patient survival
Distinguishing true tumor progression (TP) from treatment-induced abnormalities (eg, pseudo-progression (PP) after radiotherapy) on conventional MRI scans remains challenging in patients with a glioblastoma. We aimed to establish brain MRI phenotypes of glioblastomas early after treatment by combined analysis of structural and perfusion tumor characteristics and assessed the relation with recurrence rate and overall survival time. Structural and perfusion MR images of 67 patients at 3 months post-radiotherapy were visually scored by a neuroradiologist. In total 23 parameters were predefined and used for hierarchical clustering analysis. Progression status was assessed based on the clinical course of each patient 9 months after radiotherapy (or latest available). Multivariable Cox regression models were used to determine the association between the phenotypes, recurrence rate, and overall survival. We established 4 subgroups with significantly different tumor MRI characteristics, representing distinct MRI phenotypes of glioblastomas: TP and PP rates did not differ significantly between subgroups. Regression analysis showed that patients in subgroup 1 (characterized by having mostly small and ellipsoid nodular enhancing lesions with some hyper-perfusion) had a significant association with increased mortality at 9 months (HR: 2.6 (CI: 1.1–6.3); P = .03) with a median survival time of 13 months (compared to 22 months of subgroup 2). Our study suggests that distinct MRI phenotypes of glioblastomas at 3 months post-radiotherapy can be indicative of overall survival, but does not aid in differentiating TP from PP. The early prognostic information our method provides might in the future be informative for prognostication of glioblastoma patients.
- Open Access
Functional brain network and trail making test changes after major surgery and delirium
Background Delirium is a frequent complication of elective surgery in elderly patients, associated with an increased risk of long-term cognitive impairment and dementia. Disturbances in the functional brain network were previously reported during delirium. We hypothesized persisting alterations in functional brain networks three months after elective surgery in patients with postoperative delirium, and hypothesized that postoperative brain connectivity changes (irrespective of delirium) are related to cognitive decline. Methods Elderly patients (N=554) undergoing elective surgery underwent clinical assessments (including Trail Making Test B (TMT-B) and resting-state functional magnetic resonance imaging (rs-fMRI) before and three months after surgery. Delirium was assessed on the first seven postoperative days. After strict motion correction, rs-fMRI connectivity strength and network characteristics were calculated in 246 patients (130 patients underwent scans at both timepoints), of whom 38 (16%) developed postoperative delirium. Results Rs-fMRI functional connectivity strength increased after surgery in the total study population (β=0.006, 95%CI=0.000–0.012, p=0.021), but decreased after postoperative delirium (β=-0.014, 95%CI=0.000–0.012, p=0.026). No difference in TMT-B scores was found at follow-up between patients with and without postoperative delirium. Patients who decreased in functional connectivity strength declined in TMT-B scores compared to the group that did not (β=11.04, 95%CI=0.85-21.2, p=0.034). Conclusions Delirium was associated with decreased functional connectivity strength three months after the syndrome was clinically resolved, which implies that delirium has lasting impact on brain networks. Decreased connectivity strength was associated with statistically significant (but not necessarily clinically relevant) cognitive deterioration after major surgery, which was not specifically related to delirium. Summary statement Delirium was associated with decreased resting-state fMRI functional connectivity strength three months after the syndrome was clinically resolved. Irrespective of delirium, decreased connectivity strength after major surgery was associated with a statistically significant cognitive deterioration.
Open AccessFunctional brain network and trail making test changes after major surgery and delirium
Background Delirium is a frequent complication of elective surgery in elderly patients, associated with an increased risk of long-term cognitive impairment and dementia. Disturbances in the functional brain network were previously reported during delirium. We hypothesized persisting alterations in functional brain networks three months after elective surgery in patients with postoperative delirium, and hypothesized that postoperative brain connectivity changes (irrespective of delirium) are related to cognitive decline. Methods Elderly patients (N=554) undergoing elective surgery underwent clinical assessments (including Trail Making Test B (TMT-B) and resting-state functional magnetic resonance imaging (rs-fMRI) before and three months after surgery. Delirium was assessed on the first seven postoperative days. After strict motion correction, rs-fMRI connectivity strength and network characteristics were calculated in 246 patients (130 patients underwent scans at both timepoints), of whom 38 (16%) developed postoperative delirium. Results Rs-fMRI functional connectivity strength increased after surgery in the total study population (β=0.006, 95%CI=0.000–0.012, p=0.021), but decreased after postoperative delirium (β=-0.014, 95%CI=0.000–0.012, p=0.026). No difference in TMT-B scores was found at follow-up between patients with and without postoperative delirium. Patients who decreased in functional connectivity strength declined in TMT-B scores compared to the group that did not (β=11.04, 95%CI=0.85-21.2, p=0.034). Conclusions Delirium was associated with decreased functional connectivity strength three months after the syndrome was clinically resolved, which implies that delirium has lasting impact on brain networks. Decreased connectivity strength was associated with statistically significant (but not necessarily clinically relevant) cognitive deterioration after major surgery, which was not specifically related to delirium. Summary statement Delirium was associated with decreased resting-state fMRI functional connectivity strength three months after the syndrome was clinically resolved. Irrespective of delirium, decreased connectivity strength after major surgery was associated with a statistically significant cognitive deterioration.
- Open Access
- 1 May 2021
- Published by Elsevier in Neurobiology of Aging
- Vol. 101, 247-255
Preoperative MRI brain phenotypes are related to postoperative delirium in older individuals
- 1 May 2021
- Published by Elsevier in Neurobiology of Aging
- Vol. 101, 247-255
Open AccessPreoperative MRI brain phenotypes are related to postoperative delirium in older individuals